TransCode Therapeutics, Inc. (RNAZ) has 12 identified peers for comparison in the Healthcare sector. Peers include CGTX, CNSP, EFTR, EYEN, IMMX, KOD and others.
RNAZ has a market capitalization of $8.16M, compared to an average peer market cap of $282.75M. RNAZ is notably smaller than its average peer.
